Chances for licensing-in of new drugs from abroad more difficult.

As most of foreign multinational drug corporations already established their business presence in Korea, it is far less chances for domestic drug companies to make a licensing business tie-up with foreign research companies.

Having realized the importance of pipeline products in their business management, the local drug companies have tried to contact with foreign pipeline product suppliers ...